All authors are with the College of Health Solutions, Arizona State University, Phoenix. Jeffrey McCullough is also with the University of Minnesota, Minneapolis.
Am J Public Health. 2021 May;111(5):860-866. doi: 10.2105/AJPH.2021.306157. Epub 2021 Mar 18.
The COVID-19 pandemic has precipitated an acute blood shortage for medical transfusions, exacerbating an already tenuous blood supply system in the United States, contributing to the public health crisis, and raising deeper questions regarding emergency preparedness planning for ensuring blood availability. However, these issues around blood availability during the pandemic are related primarily to the decline in supply caused by reduced donations during the pandemic rather than increased demand for transfusion of patients with COVID-19.The challenges to ensure a safe blood supply during the pandemic will continue until a vaccine is developed, effective treatments are available, or the virus goes away. If this virus or a similar virus were capable of transmission through blood, it would have a catastrophic impact on the health care system, causing a future public health emergency that would jeopardize the national blood supply.In this article, we identify the impact of the COVID-19 pandemic on blood supply adequacy, discuss the public health implications, propose recovery strategies, and present recommendations for preparing for the next disruption in blood supply driven by a public health emergency.
COVID-19 大流行导致用于医疗输血的血液急性短缺,使美国本已脆弱的血液供应系统进一步恶化,加剧了公共卫生危机,并引发了关于确保血液供应的应急准备规划的更深层次问题。然而,大流行期间血液供应方面的这些问题主要与大流行期间捐赠减少导致的供应下降有关,而不是与 COVID-19 患者输血的需求增加有关。在开发出疫苗、获得有效的治疗方法或病毒消失之前,确保大流行期间安全血液供应的挑战将持续存在。如果这种病毒或类似的病毒能够通过血液传播,它将对医疗保健系统造成灾难性影响,引发未来的公共卫生紧急情况,危及国家的血液供应。在本文中,我们确定了 COVID-19 大流行对血液供应充足性的影响,讨论了其对公共卫生的影响,提出了恢复策略,并就如何为下一次由公共卫生紧急情况引发的血液供应中断做好准备提出了建议。